Interview with Dr. Charles Chabert – Laparoscopic Urology Australia We conducted this interview with Dr. Charles Chabert to get some insight into the new treatment. The effectiveness of it, processes and his feelings about it. What is Benign Prostatic Hyperplasia (BHP)? BPH refers to a benign enlargement of the prostate which is universal in all…

The US Food and Drug Administration recently approved Urolift, a new minimally invasive treatment for men who suffer blocked urine flow due to an enlarged prostate. The Urolift system is manufactured by NeoTract Inc., California, and is the first permanent implant to relieve partially or completely blocked urine flow in men aged 50 and over…

This guest blog post is written by Dr Nick Brook who is a Consultant Urologist and Director of Urological Cancer at the Department of Urology, Royal Adelaide Hospital. He is also a Clinical Associate Professor in Surgery at the University of Adelaide. His private practice is based in North Adelaide.  Inflatable penile prosthesis for erectile…

Urolift is a new minimally invasive treatment for men who suffer urinary symptoms related to BPH (benign prostatic hyperplasia or prostate enlargement).The first UroLift implants in Queensland will be performed at Pindara Private Hospital, Gold Coast, towards the end of this month.This is an exciting time for the management of urinary symptoms related to prostate…

Moxy Fibre and 180W XPS have become a standard of care at LUA and John Flynn Hospital – the first such program in Queensland. Over 200 cases of GreenLight Laser Prostatectomies have now been performed by Dr Chabert at LUA. A typical treatment episode lasts around 30-45 minutes, with the majority of patients being treated…

Website design by Phancybox